The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $125.73

Today's change0.00 0.00%
Updated July 28 4:02 PM EDT. Delayed by at least 15 minutes.
 

USANA Health Sciences Inc

NYSE: USNA
Last

(U.S.) $125.73

Today's change0.00 0.00%
Updated July 28 4:02 PM EDT. Delayed by at least 15 minutes.

USANA Health Sciences Inc closed at (U.S.)$125.73.

Shares have lost 0.28% over the last five days, but have gained 22.56% over the last year to date. This security has outperformed the S&P 500 by 74.76% during the last year.

Key company metrics

  • Open(U.S.) $125.10
  • Previous close(U.S.) $125.73
  • High(U.S.) $126.83
  • Low(U.S.) $122.56
  • Bid / Ask-- / --
  • YTD % change+22.56%
  • Volume125,553
  • Average volume (10-day)130,675
  • Average volume (1-month)139,969
  • Average volume (3-month)119,714
  • 52-week range(U.S.) $63.22 to (U.S.) $145.05
  • Beta1.26
  • Trailing P/E21.03×
  • P/E 1 year forward18.76×
  • Forward PEG1.88×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $5.98
Updated July 28 4:02 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+9.64%

Based on its net profit margin of 9.64%, USANA Health Sciences Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.54%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Personal Products
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedApr 04, 201504/04/2015Jan 03, 201501/03/2015Sep 27, 201409/27/2014Jun 28, 201406/28/2014
Revenue219228192188
Total other revenue--------
Total revenue219228192188
Gross profit181190157153
Total cost of revenue38383535
Total operating expense190195163159
Selling / general / administrative151158128124
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income30332929
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax30322929
Income after tax20211919
Income tax, total1011910
Net income20211919
Total adjustments to net income--------
Net income before extra. items20211919
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items20211919
Inc. avail. to common incl. extra. items20211919
Diluted net income20211919
Dilution adjustment------0
Diluted weighted average shares13131314
Diluted EPS excluding extraordinary itemsvalue per share1.501.661.471.35
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share1.501.661.471.35